PURPOSE OF REVIEW: Important strides in the management of patients with HIV/AIDS-related lymphomas have been made in recent years. This review will discuss the role of bone marrow or peripheral stem-cell transplantation as a modality for patients with HIV and lymphoma. RECENT FINDINGS: In the era of highly active antiretroviral therapy, patients with HIV-associated lymphoma are generally being treated with standard or only slightly modified chemotherapy regimens. Autologous bone marrow and stem-cell transplant approaches in lymphoma patients have been successful. Case reports suggest that allogeneic transplantation for patients with HIV and hematologic malignancies merits further investigation. SUMMARY: High-dose hematopoietic stem-cell therapies with curative intent should be considered as standard therapeutic options in patients who otherwise are appropriate for such therapies.
PURPOSE OF REVIEW: Important strides in the management of patients with HIV/AIDS-related lymphomas have been made in recent years. This review will discuss the role of bone marrow or peripheral stem-cell transplantation as a modality for patients with HIV and lymphoma. RECENT FINDINGS: In the era of highly active antiretroviral therapy, patients with HIV-associated lymphoma are generally being treated with standard or only slightly modified chemotherapy regimens. Autologous bone marrow and stem-cell transplant approaches in lymphomapatients have been successful. Case reports suggest that allogeneic transplantation for patients with HIV and hematologic malignancies merits further investigation. SUMMARY: High-dose hematopoietic stem-cell therapies with curative intent should be considered as standard therapeutic options in patients who otherwise are appropriate for such therapies.
Authors: P S Gill; A M Levine; M Krailo; M U Rarick; C Loureiro; L Deyton; P Meyer; S Rasheed Journal: J Clin Oncol Date: 1987-09 Impact factor: 44.544
Authors: Elizabeth M Kang; Moniek de Witte; Harry Malech; Richard A Morgan; Sheila Phang; Charles Carter; Susan F Leitman; Richard Childs; A John Barrett; Richard Little; John F Tisdale Journal: Blood Date: 2002-01-15 Impact factor: 22.113
Authors: Richard F Little; Stefania Pittaluga; Nicole Grant; Seth M Steinberg; Mark F Kavlick; Hiroaki Mitsuya; Genoveffa Franchini; Martin Gutierrez; Mark Raffeld; Elaine S Jaffe; Gene Shearer; Robert Yarchoan; Wyndham H Wilson Journal: Blood Date: 2003-02-27 Impact factor: 22.113
Authors: Thomas R Spitzer; Richard F Ambinder; Jeannette Y Lee; Lawrence D Kaplan; William Wachsman; David J Straus; David M Aboulafia; David T Scadden Journal: Biol Blood Marrow Transplant Date: 2008-01 Impact factor: 5.742
Authors: Mark Bower; Neil McCall-Peat; Natalie Ryan; Liz Davies; Anne Marie Young; Srirupa Gupta; Mark Nelson; Brian Gazzard; Justin Stebbing Journal: Blood Date: 2004-07-06 Impact factor: 22.113